148 related articles for article (PubMed ID: 37467691)
1. The immunity modulation of transforming growth factor-β in malaria and other pathological process.
Wu S; Nie Q; Tan S; Liao G; Lv Y; Lv C; Chen G; Liu S
Int Immunopharmacol; 2023 Sep; 122():110658. PubMed ID: 37467691
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines.
Hanisch BR; Bangirana P; Opoka RO; Park GS; John CC
Pediatr Infect Dis J; 2015 Jul; 34(7):783-8. PubMed ID: 25886788
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Understanding the Inflammatory Response in Malaria: A Review of the Dual Role of Cytokines.
Popa GL; Popa MI
J Immunol Res; 2021; 2021():7785180. PubMed ID: 34790829
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of cytokines expression in complicated falciparum malaria with increased TGF-β and IFN-γ and decreased IL-2 and IL-12.
Lourembam SD; Sawian CE; Baruah S
Cytokine; 2013 Nov; 64(2):503-8. PubMed ID: 24012048
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of interleukin-12 (IL-12), interleukin-18 (IL-18) and transforming growth factor beta (TGF-beta) in Plasmodium falciparum malaria.
Malaguarnera L; Pignatelli S; Simporè J; Malaguarnera M; Musumeci S
Eur Cytokine Netw; 2002; 13(4):425-30. PubMed ID: 12517727
[TBL] [Abstract][Full Text] [Related]
6. Modulation of immune response in Plasmodium falciparum malaria: role of IL-12, IL-18 and TGF-beta.
Musumeci M; Malaguarnera L; Simporè J; Messina A; Musumeci S
Cytokine; 2003 Feb; 21(4):172-8. PubMed ID: 12788305
[TBL] [Abstract][Full Text] [Related]
7. In vivo, in vitro, and in silico studies suggest a conserved immune module that regulates malaria parasite transmission from mammals to mosquitoes.
Price I; Ermentrout B; Zamora R; Wang B; Azhar N; Mi Q; Constantine G; Faeder JR; Luckhart S; Vodovotz Y
J Theor Biol; 2013 Oct; 334():173-86. PubMed ID: 23764028
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Quantitative cytokine level of TNF-α, IFN-γ, IL-10, TGF-β and circulating Epstein-Barr virus DNA load in individuals with acute Malaria due to P. falciparum or P. vivax or double infection in a Malaria endemic region in Indonesia.
Budiningsih I; Dachlan YP; Hadi U; Middeldorp JM
PLoS One; 2021; 16(12):e0261923. PubMed ID: 34962938
[TBL] [Abstract][Full Text] [Related]
10. Activation of transforming growth factor beta by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule.
Omer FM; de Souza JB; Corran PH; Sultan AA; Riley EM
J Exp Med; 2003 Dec; 198(12):1817-27. PubMed ID: 14676296
[TBL] [Abstract][Full Text] [Related]
11. Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria.
Chaiyaroj SC; Rutta AS; Muenthaisong K; Watkins P; Na Ubol M; Looareesuwan S
Acta Trop; 2004 Feb; 89(3):319-27. PubMed ID: 14744558
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.
Vodovotz Y; Zamora R; Lieber MJ; Luckhart S
Curr Mol Med; 2004 Nov; 4(7):787-97. PubMed ID: 15579025
[TBL] [Abstract][Full Text] [Related]
13. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria.
Dodoo D; Omer FM; Todd J; Akanmori BD; Koram KA; Riley EM
J Infect Dis; 2002 Apr; 185(7):971-9. PubMed ID: 11920322
[TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis of Cytokine Profiles in Malaria Patients Discloses Selective Upregulation of TGF-β1, β3, and IL-9 in Mild Clinical Presentation.
Ndoricyimpaye EL; Van Snick J; Niyoyita JD; Kanimba P; Mbonimpa JB; Rutayisire R; Rutayisire R; Ndahindwa V; Cheou P; Coutelier JP; Rujeni N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293524
[TBL] [Abstract][Full Text] [Related]
15. The ability of Interleukin-10 to negate haemozoin-related pro-inflammatory effects has the potential to restore impaired macrophage function associated with malaria infection.
Tembo D; Harawa V; Tran TC; Afran L; Molyneux ME; Taylor TE; Seydel KB; Nyirenda T; Russell DG; Mandala W
Malar J; 2023 Apr; 22(1):125. PubMed ID: 37060041
[TBL] [Abstract][Full Text] [Related]
16. Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum?
Gonçalves RM; Scopel KK; Bastos MS; Ferreira MU
PLoS One; 2012; 7(9):e44394. PubMed ID: 22973442
[TBL] [Abstract][Full Text] [Related]
17. Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.
Rhee MS; Akanmori BD; Waterfall M; Riley EM
Clin Exp Immunol; 2001 Dec; 126(3):503-10. PubMed ID: 11737069
[TBL] [Abstract][Full Text] [Related]
18. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.
Li C; Sanni LA; Omer F; Riley E; Langhorne J
Infect Immun; 2003 Sep; 71(9):4850-6. PubMed ID: 12933825
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections.
Omer FM; de Souza JB; Riley EM
J Immunol; 2003 Nov; 171(10):5430-6. PubMed ID: 14607947
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
